Comparison of early (60min) and delayed (180min) acquisition of 18F-FDG PET/CT in large vessel vasculitis

Revista Espanola de Medicina Nuclear e Imagen Molecular

Volumn 32, Issue 4, 2013, Pages 222-226

  Martinez Rodriguez I ^a   del Castillo Matos, R ^a   Quirce, R ^a   Jimenez Bonilla J ^a   de Arcocha Torres, M ^a   Ortega Nava, F ^a   Rubio Vassallo, A ^a   Martinez Amador N ^a   Ibanez Bravo S ^a   Carril, J M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

18F FDG PET CT; Giant cell arteritis; Large vessel vasculitis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; INTERMETHOD COMPARISON; LARGE VESSEL VASCULITIS; MALE; PROSPECTIVE STUDY; THORACIC AORTA; VASCULITIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; TIME; DIAGNOSTIC USE;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 84879264591     PISSN: 2253654X     EISSN: 22538070     Source Type: Journal    
DOI: 10.1016/j.remn.2012.12.004     Document Type: Article

References (25)

1. Vesselle H.J., Miraldi F.D. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 1998, 18:805-823.
2. Shreve P.D., Anzai Y., Wahl R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:61-77.
3. 18F-FDG uptake on PET/CT: characterization and incidence. AJR 2007, 189:1203-1210.
4. Quirce Pisano R., Banzo Marraco I., Jiménez-Bonilla J.F., Martínez-Rodríguez I., Sainz Esteban A., Carril Carril J.M. Potential sources of diagnostic pitfall and variants in FDG-PET/CT. Rev Esp Med Nucl 2008, 27:130-159.
5. 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006, 47:1571-1576.
6. Tahara N., Tahara A., Nitta Y., Kodama N., Mizoguchi M., Kaida H., et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010, 3:1219-1228.
7. 18F-FDG uptake. J Nucl Med 2010, 51:1009-1014.
8. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med 2011, 52:77-80.
9. Okabe T., Shibata H., Shizukuishi K., Yoneyama T., Inoue T., Tateishi U. F-18 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis. Clin Nucl Med 2011, 36:350-354.
10. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999, 38:444-447.
11. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000, 108:246-249.
12. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C.O., Lehmann K., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
13. 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005, 32:674-681.
14. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006, 55:131-137.
15. 18F]-FDG PET/CT scan detected giant cell arteritis after negative temporal artery biopsy. Open Nucl Med J 2011, 3:7-9.
16. 18F-FDG PET/CT. Rev Esp Med Nucl 2012, 31:233-235.
17. 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012, 39:344-353.
18. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105:2708-2711.
19. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005, 36:2642-2647.
20. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48:1818-1824.
21. Quirce R, Jiménez-Bonilla, JF, Ortega-Nava F, Rebollo M, Palacio EJ, de Arcocha M, et al. New insight of molecular imaging into the atheroma biology: 18F-fluoride PET/CT and 18F-FDG PET/CT of 3 carotid plaques in a symptomatic neurologic patient. Clin Nucl Med. 2013;38:451-2.
22. 18F-FDG PET/CT: when to image?. J Nucl Med 2009, 50:854-857.
23. 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007, 48:227-233.
24. 18FDG PET/CT scan in the evaluation of large-vessel vasculitis. Nucl Med Commun 2012, 33:530.
25. 18F-fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol 2012, 85:e188-e194.